Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Crump

Showing results (91-100 of 183) with videos related to

Pageof 19
Sort By:
Leukemia & Lymphoma|April 6, 2011
Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials GroupRena Buckstein, John Kuruvilla, Neil Chua, et al.
British Journal of Haematology|April 24, 2015
Clinical characteristics and early treatment outcomes of follicular lymphoma in young adultsShane A Gangatharan, Manjula Maganti, John G Kuruvilla, et al.
Current Oncology (Toronto, Ont.)|April 3, 2021
Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical TrialAnca Prica, Annette E Hay, Michael Crump, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 4, 2017
The positive effect of a dedicated adolescent and young adult fertility program on the rates of documentation of therapy-associated infertility risk and fertility preservation optionsJeremy Lewin, Justin Ming Zheng Ma, Laura Mitchell, et al.
Cancer|September 24, 2004
Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)Michael Crump, Tara Baetz, Stephen Couban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16Michael Crump, Stefan Gluck, Dongsheng Tu, et al.
Leukemia & Lymphoma|June 25, 2016
FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS studyLale Kostakoglu, Andre Goy, Giovanni Martinelli, et al.
Breast Cancer Research and Treatment|April 27, 2007
A Phase 2 study of perifosine in advanced or metastatic breast cancerNatasha B Leighl, Susan Dent, Mark Clemons, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 10, 2011
Adult ovarian retinoblastoma genomic profile distinct from prior childhood eye tumorShui Yen Soh, Helen Dimaras, Abha Gupta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancerNadine Tchen, Helen G Juffs, Fiona P Downie, et al.
Pageof 19

Showing results (91-100 of 183) with videos related to

Sort By:
Pageof 19
Leukemia & Lymphoma|April 6, 2011
Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials GroupRena Buckstein, John Kuruvilla, Neil Chua, et al.
British Journal of Haematology|April 24, 2015
Clinical characteristics and early treatment outcomes of follicular lymphoma in young adultsShane A Gangatharan, Manjula Maganti, John G Kuruvilla, et al.
Current Oncology (Toronto, Ont.)|April 3, 2021
Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical TrialAnca Prica, Annette E Hay, Michael Crump, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 4, 2017
The positive effect of a dedicated adolescent and young adult fertility program on the rates of documentation of therapy-associated infertility risk and fertility preservation optionsJeremy Lewin, Justin Ming Zheng Ma, Laura Mitchell, et al.
Cancer|September 24, 2004
Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)Michael Crump, Tara Baetz, Stephen Couban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16Michael Crump, Stefan Gluck, Dongsheng Tu, et al.
Leukemia & Lymphoma|June 25, 2016
FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS studyLale Kostakoglu, Andre Goy, Giovanni Martinelli, et al.
Breast Cancer Research and Treatment|April 27, 2007
A Phase 2 study of perifosine in advanced or metastatic breast cancerNatasha B Leighl, Susan Dent, Mark Clemons, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 10, 2011
Adult ovarian retinoblastoma genomic profile distinct from prior childhood eye tumorShui Yen Soh, Helen Dimaras, Abha Gupta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancerNadine Tchen, Helen G Juffs, Fiona P Downie, et al.
Pageof 19